Navigation Links
Bird Flu Expected To Hit U.S. This Summer

The California officials are expecting bird flu arrive at the U.S. West Coast this summer, making what could be the first sign in the United States of the deadly virus. // The deadly H5N1 virus has already swept from Asia across Europe and down to Africa. This announcement was made by California Health and Human Services Secretary Kim Belshe told reporters on Thursday at a state bird flu pandemic preparedness meeting.

Officials said the virus was likely to arrive into either the east or west coast of the United States by migrating birds starting their journeys south. They said some 60,000 birds, mostly waterfowl, would begin their migration south from Alaska in mid-August, working their way down through Oregon, Washington and into California.

U.S. Health and Human Services Secretary Michael Leavitt warned against panic when the flu hits US, saying it need not inevitably mean the start of a human pandemic. He said that it would quite certain that a wild bird with H5N1 will hit US, but he said that, it was not necessarily a crisis. Leavitt and other health and government officials urged local governments, schools, businesses and individual families to begin preparing now for a health disaster. He further warned on Monday, that there would be no way that a national government could respond to 5,000 locations at the same time. He stated that it would be very wrong for any community not preparing thinking that the federal government will come to the rescue.

Leavitt also said research published on Wednesday, they are working to develop vaccine and an adjuvant technology that will allow us to boost the effects of vaccine and are optimistic that that can be part of the solution. GlaxoSmithKline on Thursday announced the start of human trials of two new bird flu vaccines using adjutant (additives that are put into vaccines that boost the immune system and make it respond more efficiently). If the vaccines work they would be ready to manufact
'"/>




Page: 1 2

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. Medicare Queries Expected To Increase Over Time
3. Asia Expected To Witness More Human Bird Flu Cases
4. Mexi-Plan by Health Net, Expected To Be a Boon for Uninsured Latinos
5. Hunt for Common Genes linked to Cancer Expected to be Unsuccessful
6. Drug Addicts In US Expected To Double By 2020
7. National Autism Conference In US Expected To Draw Thousands In Attendance
8. Flu Vaccines Expected to Meet Needs Completely
9. HIV Children Live Longer Than Expected
10. Fertility Treatment Offered During Summer Has Better Chances For Success
11. Footwear The Hot Pick Of Summer Fashion In The West
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bird Flu Expected Hit This Summer

(Date:12/6/2009)... Calif., Dec. 6 Pharmacyclics, Inc. (Nasdaq: ... a Phase I/II study showing safety and clinical ... Lymphoma (NHL) treated with its HDAC inhibitor PCI-24781 ... today at the 51st ASH Annual Meeting being ... ,, PCI-24781 is an oral pan-HDAC inhibitor ...
(Date:12/6/2009)... Findings offer hope for future treatments targeting growth factor, ... -- The spread of breast cancer cells from the ... controlled by a growth factor known as TGFb, which ... prevent metastatic breast cancer, British researchers say. , Previous ... regulates normal cell growth and movement. In this new ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...
(Date:12/6/2009)... organizations and members of the community, in cooperation with the Greater ... a holiday party. This year,s attendance is expected to soar to ... , ... (PRWEB) December 6, 2009 -- Volunteer ... VA Healthcare System in West Los Angeles, will once again create ...
(Date:12/5/2009)... ,, What: Cuts for a Cause ... the fight against cancer and other terminal illnesses affecting children. ... to St. Jude Children,s Research Hospital. Guests will enjoy complimentary ... and savory Vietnamese restaurant in Falls Church for all guests. ...
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Breast Cancer's Spread Now Better Understood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3
... April 17 In recognition of the 20th anniversary of ... global hemophilia community by pledging euro 250,000 to the World ... around the world will engage in activities to support the ... and promote support for the needs of people living with ...
... view the likely outcome of breast augmentation surgery before the procedure ... is taking advantage of it. , ... (Vocus) April ... breast surgery is typically: ‘What will I look like after the ...
... TransparencyEL SEGUNDO, Calif., April 17 DaVita Inc., a ... with chronic kidney disease, today acknowledged its being named ... company and only healthcare company to make the 2009 ... in 1999. This is the second year the ...
... team of scientists from the University of Leicester could ... a powerful new strategy for both the early diagnosis ... is to use cutting edge nanotechnology to identify a ... aggressive cancers. , The University of Leicester researchers say ...
... limit prevention of blindness, experts say , , THURSDAY, April ... not prevent the development of blindness-causing macular edema in ... new study has found. , About 50 percent of ... of those with type 2 diabetes develop retinopathy, which ...
... for Statewide Health Information Network for New York ... eHealth Collaborative (NYeC) has partnered with global eHealth ... the country,s largest electronic prescribing network, for an ... with a patient,s consent, deliver prescription history for ...
Other Medicine News:Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 2Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 3Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 4Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 5Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 2Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 3Health News:DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999 2Health News:Pioneering medical nanotechnology offers new cancer breakthrough hope 2Health News:Drug May Not Help Diabetes-Related Eye Damage 2Health News:ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY 2Health News:ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY 3Health News:ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY 4
(Date:12/4/2009)... Bayer Diabetes Care today announced the three grand prize winners ... of the Jonas Brothers, selected the winning video entries submitted ... prize is an in-person meeting today with Nick. ... are: Caleb, age 6, from Danbury, CT, who dreams of ...
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... and Trademark Office has allowed its patent application on ... the manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... very high concentration of dendritic cells (which are the ...
(Date:12/4/2009)... Depression, anxiety disorder, bipolar disorder, Attention Deficit ... are among the comorbidities reported to occur more ... diagnosed with epilepsy versus those without an epilepsy ... households across the U.S. ,, Findings from " ...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3International conference on endothelin 9866 1International conference on endothelin 9866 2International conference on endothelin 9866 3Sex talk revelations of the lonely Y chromosome 9861 1Sex talk revelations of the lonely Y chromosome 9861 2Martek Announces Settlement of Patent Dispute with Capsugel France 13980 1Martek Announces Settlement of Patent Dispute with Capsugel France 13980 2
... PGL; Nasdaq: PGLA) today announced additional,data from the Phase ... This data was presented at the 58th Annual Meeting ... in Boston, USA(1). As the Phase 2 trial,s ... analysis described in this presentation was performed to,evaluate the ...
... as many injections as standard therapy, and, demonstrated at least comparable ... impairment of quality of life on treatment -,- ... presented at the Annual Meeting of the American Association for ... the Study of Liver Diseases (AASLD) -, ROCKVILLE, Md., Nov. 5 ...
Other Medicine Technology:Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 2Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 3Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 4Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 5Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 6Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 7Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 8
... made of Kydex and soft ... back sections are adjustable in ... facilitate air circulation and tube ... washable. Model C-18 is available ...
Foam Cervical Collar is medium-firm density. Breathable. Deeply anatomically contoured. Natural color, 100% cotton stockinette-covered for comfort. 2" hook and loop closures are another mark of quali...
Ezy Wrap® Economy Contour Cervical Collar Medium-density urethane foam. Synthetic white stockinette cover. Reverses for flexion or extension. (Contact closure. Hand wash. Air dry. 10/pack.)...
Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar...
Medicine Products: